HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reverse-Switch Of Stada’s Lemocin On The Agenda Of Germany's Switch Committee

Executive Summary

Germany's Expert Committee for Prescription will consider the reverse-switch of tyrothricin – a key ingredient in Stada's recently-acquired Lemocin throat lozenge – to presciption-only status and the Rx-to-OTC switch of soluble fluoride tablets for the oral treatment of osteoporosis.

You may also be interested in...

OTC Switch Brands Voltaren, Pataday Are Fast On Their Feet Following US Approval To Drive Sales

Consultant Susan Levy points out Alcon’s Pataday eye drops and GSK's Voltaren Arthritis Relief as examples of effective switch advertising, marketing and management. Pfizer’s Advil line has been available far longer but also is an example of effective nonprescription brand management.

Italy Gives Adolescents OTC Access To Morning After Pill

HRA Pharma's EllaOne emergency contraceptive is now available OTC for Italian adolescents under the age of 18 with the country's drug agency hoping the move will empower young women to take greater control over their lives.

Fortacin Wins Commission Approval As Fifth EU-Wide Rx-To-OTC Switch

European Commission approval of Fortacin as OTC premature ejaculation treatment makes it only the fifth drug switched EU-wide through the centralized procedure. 

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts